Soc. Generale Knock-Out MRK/ DE000SD4MA43 /
2024-06-05 5:54:33 PM | Chg.+0.04 | Bid6:28:36 PM | Ask6:28:36 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.66EUR | +0.87% | 4.66 Bid Size: 80,000 |
4.67 Ask Size: 80,000 |
Merck and Co Inc | 79.0565 USD | 2078-12-31 | Call |
GlobeNewswire
05-28
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire
05-23
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
05-16
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-14
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire
05-08
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
04-24
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Onc...
GlobeNewswire
04-15
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire
04-09
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer...
GlobeNewswire
03-18
Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D...
GlobeNewswire
03-15
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...